The appointment follows a reshuffle following the €55 billion link-up
between French drug major Sanofi-Synthelabo and Franco-German peer Aventis this summer.
Sanofi-Aventis has also named Jose Lourenzo (from the Sanofi side) as Pujol’s counterpart in Portugal.
Pujol, 57, was previously external comms director at Sanofi in Spain. She will now oversee media relations, internal and external relations, intranet and internet comms.
Aventis’ former comms boss Pedro Gonzalez will work under Pujol, handling product publicity, while May Martin Lunas will supervise media relations. The 4-strong team will be based in Madrid excepting Alicia Delgado who will head internal comms from Barcelona.
Pujol will report to Sanofi-Aventis’ Spain director general Belen Garijo.
Pujol’s mandate will be to spread the word in Spain about the new Sanofi-Aventis, which is billed as Europe’s biggest drugs company.
‘My goal is to increase the knowledge of the company and its products portfolio outside and inside the company. I want everyone from directors, factory workers and sales people to know our products and our communications policy,’ Pujol said.
To that end, she will schedule interviews between Garijo and the Spanish press and organize media events to ‘communicate heavily and frequently,’ she said.
This year and next Pujol will be particularly busy with the Spanish launch of the firm’s new anti-smoking and obesity drug Acomplia in mid 2006.
To communicate internally, Pujol will merge Sanofi’s employees newsletter with Aventis’ intranet and organize activities to get staff involved with comms.